Back

Wild type AAV, recombinant AAV, and Adenovirus super infection impact on AAV vector mobilization

Song, L.; Samulski, R. J.; Hirsch, M. L.

2020-05-13 microbiology
10.1101/2020.05.13.094201 bioRxiv
Show abstract

Recombinant Adeno-associated viral vector (rAAV) mobilization is a largely theoretical process in which intact AAV vectors spread or "mobilize" from transduced cells and infect additional cells within, or external, of the initial host. This process can be replication independent (vector alone), or replication-dependent (de novo rAAV production facilitated by super-infection of both wild-type AAV (wtAAV) and Ad helper virus). Herein, rAAV production and mobilization with and without wtAAV were analyzed following plasmid transfection or viral transduction utilizing well established in vitro conditions and analytical measurements. During in vitro production, wtAAV produced the highest titer with rAAV-luc (4.1 Kb), rAAV-IDUA (3.7 Kb), and rAAV-NanoDysferlin (4.9 Kb) generating 2.5-, 5.9-, or 10.7-fold lower amounts, respectively. Surprisingly, cotransfection of a wtAAV and a rAAV plasmid resulted in a uniform decrease in production of wtAAV in all instances with a concomitant increase of rAAV such that wtAAV:rAAV titers were at a ratio of 1:1 for all constructs investigated. These results were shown to be independent of the rAAV transgenic sequence, size, transgene, or promoter choice and point to novel aspects of wtAAV complementation that enhance current vector production systems yet to be de fined. In a mobilization assay, a sizeable amount of rAAV recovered from infected 293 cell lysate remained intact and competent for a secondary round of infection (termed non-replicative mobilization). In rAAV infected cells co-infected with Ad5 and wtAAV, rAAV particle production was increased > 50-fold compared to non-replicative conditions. In addition, replicative dependent rAAV vectors mobilized and resulted in >1,000 -fold transduction upon a subsequent 2nd round infection, highlighting the reality of these theoretical safety concerns that can be manifested under various conditions. Overall, these studies document and signify the need for mobilization resistant vectors and the opportunity to derive better vector production systems.

Matching journals

The top 1 journal accounts for 50% of the predicted probability mass.

1
Molecular Therapy - Methods & Clinical Development
38 papers in training set
Top 0.1%
50.5%
50% of probability mass above
2
Scientific Reports
3102 papers in training set
Top 17%
6.4%
3
PLOS ONE
4510 papers in training set
Top 33%
4.4%
4
Frontiers in Bioengineering and Biotechnology
88 papers in training set
Top 0.6%
3.6%
5
Molecular Therapy Methods & Clinical Development
13 papers in training set
Top 0.1%
3.6%
6
Viruses
318 papers in training set
Top 2%
2.6%
7
Journal of Virology
456 papers in training set
Top 2%
2.4%
8
Journal of General Virology
46 papers in training set
Top 0.3%
1.8%
9
ACS Synthetic Biology
256 papers in training set
Top 2%
1.7%
10
eLife
5422 papers in training set
Top 41%
1.7%
11
Nature Communications
4913 papers in training set
Top 53%
1.5%
12
Nucleic Acids Research
1128 papers in training set
Top 15%
0.9%
13
Molecular Therapy Nucleic Acids
32 papers in training set
Top 0.7%
0.8%
14
Biology Methods and Protocols
53 papers in training set
Top 2%
0.8%
15
Frontiers in Microbiology
375 papers in training set
Top 9%
0.8%
16
Journal of Virological Methods
36 papers in training set
Top 0.7%
0.8%
17
JCI Insight
241 papers in training set
Top 8%
0.7%
18
Metabolic Engineering
68 papers in training set
Top 0.7%
0.7%
19
Journal of Visualized Experiments
30 papers in training set
Top 0.8%
0.7%
20
Frontiers in Neuroanatomy
14 papers in training set
Top 0.1%
0.6%
21
International Journal of Molecular Sciences
453 papers in training set
Top 20%
0.5%
22
Emerging Infectious Diseases
103 papers in training set
Top 4%
0.5%